Skip to main content

What the FDA labels say about taking them together

Alprazolam and fluoxetine

Fluoxetine's FDA label of January 8, 2026 names alprazolam in its drug interactions section; the alprazolam labels PlainMeds reads (2) do not name fluoxetine. The fluoxetine label: “Diazepam – increased t½, alprazolam - further psychomotor performance decrement due to increased levels Antipsychotics:”

Check it at the source: the alprazolam FDA label on DailyMed (effective January 18, 2023, PHARMACIA & UPJOHN COMPANY LLC); the fluoxetine FDA label on DailyMed (effective January 8, 2026, Dista Products Company).

What does the alprazolam label say about fluoxetine?

Alprazolam's label (effective January 18, 2023) and its 1 other brand-application label do not name fluoxetine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xanax), PHARMACIA & UPJOHN COMPANY LLC, effective January 18, 2023 (SPL set 388e249d-b9b6-44c3-9f8f-880eced0239f), via openFDA; the full label on DailyMed

What does the fluoxetine label say about alprazolam?

Fluoxetine label, drug interactions

Diazepam – increased t½, alprazolam - further psychomotor performance decrement due to increased levels ( 7.7 ) Antipsychotics:

Source: FDA drug label (Prozac), NDA018936 (Eli Lilly And Co), as published by Dista Products Company, effective January 8, 2026 (SPL set c88f33ed-6dfb-4c5e-bc01-d8e36dd97299), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

30Alprazolam generic labelers
58Fluoxetine generic labelers
AlprazolamFluoxetine
Labeled forAnxietyDepression, Anxiety, Bipolar disorder
Boxed warningYesYes
Pharmacy cost (NADAC)$0.0236 per tablet 0.25 mg tablet$0.0519 per capsule 40 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?